Expression of PD-1 and CTLA-4 Ligands in Invasive Bladder Cancer Mouse Models

被引：0
|
作者：
Allam, M. [1 ]
Ismail, N. F. [1 ]
Lightbody, R. [1 ]
Fraser, S. [2 ]
Sansom, O. J. [3 ]
Iwata, T. [1 ]
机构：
[1] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland
[2] Queen Elizabeth Univ Hosp, Dept Pathol, Glasgow, Lanark, Scotland
[3] Beatson Inst Canc Res, Glasgow, Lanark, Scotland
来源：
JOURNAL OF PATHOLOGY | 2016年 / 240卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [31] Optimization of CTLA-4 and PD-1 proteins in EMT6 Mouse Mammary Cancer Cells by Western Blot
    Sham, Nur Fatihah Ronny
    Hasani, Narimah Abdul Hamid
    Idorus, Mohd Yusri
    Karim, Muhammad Khalis Abdul
    Fuad, Syed Baharom Syed Ahmad
    Hasbullah, Harissa Husainy
    Ibahim, Mohammad Johari
    MALAYSIAN JOURNAL OF FUNDAMENTAL AND APPLIED SCIENCES, 2023, 19 (02): : 194 - 201
  • [32] Relationship Between the Expression of PD-1 and CTLA-4 on T Lymphocytes and the Severity and Prognosis of Sepsis
    Wang, Lang
    Zhang, Zhiqi
    Chen, Xingxiang
    Yu, Fang
    Huang, Hai
    Shen, Xue
    Tan, Yujie
    Wu, Qingqing
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 1513 - 1525
  • [33] PROGNOSTIC VALUE OF EXPRESSION OF PD-1 AND CTLA-4 IN PERIPHERAL BLOOD IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Eun, Hyuk Soo
    Lee, Tae Hee
    Lee, Jeongdong
    Kim, Min Seok
    Rou, Woo Sun
    Jeon, Hong Jae
    Kim, Seok Hyun
    Lee, Byung Seok
    Choi, Hei-Gwon
    Kim, Ha Neul
    Jang, Tae Min
    Lee, Ji Ah
    Son, Chae Yeon
    Bu, Jiyoon
    HEPATOLOGY, 2023, 78 : S1879 - S1880
  • [34] Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression
    Skafi, Najwa
    Fayyad-Kazan, Mohammad
    Badran, Bassam
    GENE, 2020, 754
  • [35] CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients
    Mohammadzadeh, Adel
    Rad, Isa Abdi
    Ahmadi-Salmasi, Babak
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 323 : 105 - 108
  • [36] CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
    Buchbinder, Elizabeth I.
    Desai, Anupam
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01): : 98 - 106
  • [37] Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma
    Landwehr, Laura-Sophie
    Altieri, Barbara
    Sbiera, Iuliu
    Remde, Hanna
    Kircher, Stefan
    Olabe, Julie
    Sbiera, Silviu
    Kroiss, Matthias
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (09): : 2325 - 2334
  • [38] BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
    Watanabe, N
    Gavrieli, M
    Sedy, JR
    Yang, JF
    Fallarino, F
    Loftin, SK
    Hurchla, MA
    Zimmerman, N
    Sim, J
    Zang, XX
    Murphy, TL
    Russell, JH
    Allison, JP
    Murphy, KM
    NATURE IMMUNOLOGY, 2003, 4 (07) : 670 - 679
  • [39] BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
    Norihiko Watanabe
    Maya Gavrieli
    John R Sedy
    Jianfei Yang
    Francesca Fallarino
    Susan K Loftin
    Michelle A Hurchla
    Natalie Zimmerman
    Julia Sim
    Xingxing Zang
    Theresa L Murphy
    John H Russell
    James P Allison
    Kenneth M Murphy
    Nature Immunology, 2003, 4 : 670 - 679
  • [40] Nonclinical evaluation of the combination of mouse IL-21 and anti- mouse CTLA-4 or PD-1 blocking antibodies in mouse tumor models
    Jure-Kunkel, Maria
    Selby, Mark
    Lewis, Katherine
    Masters, Gregg
    Valle, Jose
    Grosso, Joseph
    Dito, Gennaro
    Curtis, Wendy
    Garcia, Richard
    Holdren, Matthew
    Korman, Alan J.
    Dillon, Stacey
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345